Company / Operating Cash Flow
Regenerative Medical Technology Group Inc. Operating Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$706.5K
FY2025
5-year range
-$9.9M / $850.7K
FY2021-FY2025
Trend
-183.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 8 years, ranging from -$10M in FY2021 to $850,699 in FY2024.
Based on SEC 10-K filings.
-$706,519 in FY2025.
Declined from -$419,199 to -$706,519 over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow decreased 183.1% year-over-year.
- Peak operating cash flow was recorded in FY2024.
- Lowest operating cash flow in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$706.5K | -183.1% |
| FY2024 | $850.7K | +302.9% |
| FY2023 | -$419.2K | +62.4% |
| FY2022 | -$1.1M | +88.7% |
| FY2021 | -$9.9M | -2960.8% |
| FY2020 | -$322.7K | +10.9% |
| FY2019 | -$362.3K | -48.1% |
| FY2018 | -$244.6K | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026